Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer.

World J Gastrointest Oncol · 2020 · PMC7443840 · PMID 32879667

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a statistical trendno p-value reported

Nevertheless, a statistical trend towards the oxaliplatin/5-FU group was noticed (Figure 2 ; median survival 30 mo for MMC vs not reached for oxaliplatin/5-FU).

also in 2,561 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.